Pharmaceuticals Portfolio Pharmaceuticals Fund Holdings Turnover
| FPHAX Fund | USD 26.21 0.05 0.19% |
Pharmaceuticals Portfolio Pharmaceuticals fundamentals help investors to digest information that contributes to Pharmaceuticals Portfolio's financial success or failures. It also enables traders to predict the movement of Pharmaceuticals Mutual Fund. The fundamental analysis module provides a way to measure Pharmaceuticals Portfolio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharmaceuticals Portfolio mutual fund.
Pharmaceuticals |
Pharmaceuticals Portfolio Pharmaceuticals Mutual Fund Holdings Turnover Analysis
Pharmaceuticals Portfolio's Holding Turnover is calculated by adding up all the transactions for the year, dividing it by 2 and then dividing it again by the total fund holdings. Holding Turnover is the rate at which funds or ETFs replace their investment holdings on an annual basis. In other words it measures how quickly a fund turns over its holdings during the fiscal year.
Investor can think of Holding Turnover as a percentage of a fund's assets that have turned over in the past year. Typically, a high annual turnover ratio implies that fund managers made a lot of buying and selling. The higher the annual turnover, the higher the expense ratio for the fund.
| Competition |
According to the company disclosure, Pharmaceuticals Portfolio Pharmaceuticals has a Holdings Turnover of 0.0%. This is 100.0% lower than that of the Fidelity Investments family and about the same as Health (which currently averages 0.0) category. The holdings turnover for all United States funds is 100.0% higher than that of the company.
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Fund Asset Allocation for Pharmaceuticals Portfolio
The fund consists of 97.26% investments in stocks, with the rest of investments allocated between different money market instruments and various exotic instruments.Asset allocation divides Pharmaceuticals Portfolio's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Pharmaceuticals Fundamentals
| Price To Earning | 18.56 X | |||
| Price To Book | 2.04 X | |||
| Price To Sales | 3.00 X | |||
| Annual Yield | 0.01 % | |||
| Year To Date Return | 13.46 % | |||
| One Year Return | 24.12 % | |||
| Three Year Return | 12.93 % | |||
| Five Year Return | 14.29 % | |||
| Ten Year Return | 14.79 % | |||
| Net Asset | 863.31 M | |||
| Last Dividend Paid | 0.05 | |||
| Cash Position Weight | 1.85 % | |||
| Equity Positions Weight | 97.26 % |
About Pharmaceuticals Portfolio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharmaceuticals Portfolio Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmaceuticals Portfolio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmaceuticals Portfolio Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pharmaceuticals Portfolio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pharmaceuticals Portfolio's short interest history, or implied volatility extrapolated from Pharmaceuticals Portfolio options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Pharmaceuticals Portfolio Pharmaceuticals. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Pharmaceuticals Portfolio information on this page should be used as a complementary analysis to other Pharmaceuticals Portfolio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.